J&J's Janssen Gets European OK for Stelara in Ulcerative Colitis

Date : 09/04/2019 @ 3:05PM
Source : Dow Jones News
Stock : Johnson and Johnson (JNJ)
Quote : 131.33  0.0 (0.00%) @ 10:27AM

J&J's Janssen Gets European OK for Stelara in Ulcerative Colitis

Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart

2 Months : From Aug 2019 to Oct 2019

Click Here for more Johnson and Johnson Charts.

By Colin Kellaher


Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit on Wednesday said the European Commission approved the expanded use of Stelara in adults with the inflammatory bowel disease ulcerative colitis.

Janssen said the approval covers adults with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies.

The European Medicines Agency's Committee for Medicinal Products for Human Use in July recommended the expanded marketing authorization of Stelara, which was approved in 2016 for the inflammatory bowel disorder Crohn's disease.

The U.S. Food and Drug Administration is currently reviewing Janssen's application for Stelara in adults with ulcerative colitis.


Write to Colin Kellaher at colin.kellaher@wsj.com


(END) Dow Jones Newswires

September 04, 2019 09:50 ET (13:50 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest JNJ Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.